RESPIRERX PHARMACEUTICALS INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/03c3fd8a-d9fc-4ec3-a134-7b8c593a9d96/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-2.1M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-012542 |
| FY 2021 | $-3.1M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010053 |
| FY 2020 | $4.3M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-012652 |
| FY 2019 | $2.1M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-009546 |
| FY 2018 | $-2.6M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-005477 |
| FY 2017 | $-4.3M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-005325 |
| FY 2016 | $-9.2M | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003145 |
| FY 2015 | $-6.0M | 2015-01-01 – 2015-12-31 | evidence 0001493152-16-008331 |
| FY 2014 | $-2.7M | 2014-01-01 – 2014-12-31 | evidence 0001493152-15-001071 |
| FY 2013 | $-1.2M | 2013-01-01 – 2013-12-31 | evidence 0001493152-15-000058 |
| FY 2012 | $-7.6M | 2012-01-01 – 2012-12-31 | evidence 0001493152-14-003313 |
| FY 2011 | $-2.3M | 2011-01-01 – 2011-12-31 | evidence 0001493152-14-002330 |
| FY 2010 | $1.6M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-143643 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
RESPIRERX PHARMACEUTICALS INC. — all facts · Revenue · Operating Income